Analysts Set Agilent Technologies Inc (NYSE:A) Price Target at $83.92

Agilent Technologies Inc (NYSE:A) has earned an average recommendation of “Buy” from the fifteen analysts that are covering the firm, MarketBeat Ratings reports. Seven research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 12 month target price among brokers that have covered the stock in the last year is $83.92.

Several analysts have recently commented on the stock. UBS Group increased their price target on shares of Agilent Technologies from $82.00 to $87.00 and gave the company a “neutral” rating in a research note on Tuesday, November 26th. Zacks Investment Research cut shares of Agilent Technologies from a “buy” rating to a “hold” rating and set a $75.00 price objective on the stock. in a research note on Monday, August 19th. Needham & Company LLC reaffirmed a “buy” rating and issued a $85.00 price objective (down from $92.00) on shares of Agilent Technologies in a research note on Tuesday, November 26th. Barclays reduced their price objective on shares of Agilent Technologies from $78.00 to $76.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 9th. Finally, Stifel Nicolaus started coverage on shares of Agilent Technologies in a research note on Thursday, November 14th. They issued a “hold” rating and a $85.00 price objective on the stock.

NYSE:A traded down $1.10 during mid-day trading on Tuesday, hitting $83.71. The company’s stock had a trading volume of 1,811,165 shares, compared to its average volume of 1,991,673. Agilent Technologies has a fifty-two week low of $62.00 and a fifty-two week high of $84.98. The company has a current ratio of 1.53, a quick ratio of 1.21 and a debt-to-equity ratio of 0.38. The company has a market capitalization of $26.25 billion, a price-to-earnings ratio of 26.92, a P/E/G ratio of 1.99 and a beta of 1.43. The stock has a fifty day moving average of $78.76 and a 200-day moving average of $73.80.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Monday, November 25th. The medical research company reported $0.89 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.86 by $0.03. The firm had revenue of $1.37 billion during the quarter, compared to analyst estimates of $1.33 billion. Agilent Technologies had a net margin of 20.74% and a return on equity of 20.13%. The company’s quarterly revenue was up 5.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.81 earnings per share. On average, equities analysts anticipate that Agilent Technologies will post 3.41 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.86%. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.16. The ex-dividend date is Monday, December 30th. Agilent Technologies’s dividend payout ratio (DPR) is presently 21.22%.

In other Agilent Technologies news, Director Heidi Fields sold 4,000 shares of Agilent Technologies stock in a transaction on Friday, September 20th. The shares were sold at an average price of $78.56, for a total value of $314,240.00. Following the sale, the director now directly owns 53,287 shares in the company, valued at approximately $4,186,226.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Mark Doak sold 8,016 shares of Agilent Technologies stock in a transaction on Thursday, December 12th. The shares were sold at an average price of $84.50, for a total transaction of $677,352.00. Following the completion of the sale, the vice president now owns 142,017 shares in the company, valued at $12,000,436.50. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 76,288 shares of company stock worth $6,247,546.

A number of hedge funds have recently modified their holdings of A. Capital Investment Advisory Services LLC bought a new stake in Agilent Technologies in the 2nd quarter valued at about $26,000. Liberty Wealth Management LLC acquired a new position in shares of Agilent Technologies in the 2nd quarter valued at approximately $29,000. WealthStone Inc. acquired a new position in shares of Agilent Technologies in the 2nd quarter valued at approximately $31,000. Coastal Capital Group Inc. acquired a new position in shares of Agilent Technologies in the 2nd quarter valued at approximately $32,000. Finally, Whittier Trust Co. of Nevada Inc. raised its position in shares of Agilent Technologies by 185.5% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 471 shares of the medical research company’s stock valued at $36,000 after buying an additional 306 shares in the last quarter.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Featured Article: Hedge Funds – Risk or Reward?

Analyst Recommendations for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.